Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mason

Showing results (1321-1330 of 1,358) with videos related to

Pageof 136
Sort By:
Magnetic Resonance in Medicine|September 21, 2022
The future of MRI in radiation therapy: Challenges and opportunities for the MR communityRosie J Goodburn, Marielle E P Philippens, Thierry L Lefebvre, et al.
American Journal of Respiratory and Critical Care Medicine|July 3, 2013
An official American Thoracic Society/International Society for Heart and Lung Transplantation/Society of Critical Care Medicine/Association of Organ and Procurement Organizations/United Network of Organ Sharing Statement: ethical and policy considerations in organ donation after circulatory determination of deathCynthia J Gries, Douglas B White, Robert D Truog, et al.
Developmental Cell|November 1, 2002
Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesisSang Sun Yoon, Robert F Hennigan, George M Hilliard, et al.
The Lancet. Oncology|October 1, 2016
Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup studyJaap C Reijneveld, Martin J B Taphoorn, Corneel Coens, et al.
The Lancet. Oncology|March 10, 2009
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialRoger Stupp, Monika E Hegi, Warren P Mason, et al.
Physical Review Letters|October 15, 2008
Probing the order-to-chaos region in superdeformed 151Tb and 196Pb nuclei with continuum gamma transitionsS Leoni, G Benzoni, N Blasi, et al.
Neuro-Oncology|April 4, 2017
Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOGDeborah T Blumenthal, Thierry Gorlia, Mark R Gilbert, et al.
European Journal of Cancer (Oxford, England : 1990)|March 24, 2018
Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trialY Gao, B Weenink, M J van den Bent, et al.
The New England Journal of Medicine|March 16, 2017
Short-Course Radiation plus Temozolomide in Elderly Patients with GlioblastomaJames R Perry, Normand Laperriere, Christopher J O'Callaghan, et al.
The Lancet. Oncology|November 28, 2021
Dabrafenib plus trametinib in patients with BRAF<sup>V600E</sup>-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trialPatrick Y Wen, Alexander Stein, Martin van den Bent, et al.
Pageof 136

Showing results (1321-1330 of 1,358) with videos related to

Sort By:
Pageof 136
Magnetic Resonance in Medicine|September 21, 2022
The future of MRI in radiation therapy: Challenges and opportunities for the MR communityRosie J Goodburn, Marielle E P Philippens, Thierry L Lefebvre, et al.
American Journal of Respiratory and Critical Care Medicine|July 3, 2013
An official American Thoracic Society/International Society for Heart and Lung Transplantation/Society of Critical Care Medicine/Association of Organ and Procurement Organizations/United Network of Organ Sharing Statement: ethical and policy considerations in organ donation after circulatory determination of deathCynthia J Gries, Douglas B White, Robert D Truog, et al.
Developmental Cell|November 1, 2002
Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesisSang Sun Yoon, Robert F Hennigan, George M Hilliard, et al.
The Lancet. Oncology|October 1, 2016
Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup studyJaap C Reijneveld, Martin J B Taphoorn, Corneel Coens, et al.
The Lancet. Oncology|March 10, 2009
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialRoger Stupp, Monika E Hegi, Warren P Mason, et al.
Physical Review Letters|October 15, 2008
Probing the order-to-chaos region in superdeformed 151Tb and 196Pb nuclei with continuum gamma transitionsS Leoni, G Benzoni, N Blasi, et al.
Neuro-Oncology|April 4, 2017
Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOGDeborah T Blumenthal, Thierry Gorlia, Mark R Gilbert, et al.
European Journal of Cancer (Oxford, England : 1990)|March 24, 2018
Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trialY Gao, B Weenink, M J van den Bent, et al.
The New England Journal of Medicine|March 16, 2017
Short-Course Radiation plus Temozolomide in Elderly Patients with GlioblastomaJames R Perry, Normand Laperriere, Christopher J O'Callaghan, et al.
The Lancet. Oncology|November 28, 2021
Dabrafenib plus trametinib in patients with BRAF<sup>V600E</sup>-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trialPatrick Y Wen, Alexander Stein, Martin van den Bent, et al.
Pageof 136